![Pharmaceutics | Free Full-Text | Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives | HTML Pharmaceutics | Free Full-Text | Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01117/article_deploy/html/images/pharmaceutics-14-01117-g001.png)
Pharmaceutics | Free Full-Text | Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives | HTML
![PDF) Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines PDF) Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines](https://i1.rgstatic.net/publication/339522204_Phosphotyrosine-based_Phosphoproteomics_for_Target_Identification_and_Drug_Response_Prediction_in_AML_Cell_Lines/links/5e571fe94585152ce8f284ef/largepreview.png)
PDF) Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy an
![IJERPH | Free Full-Text | Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention | HTML IJERPH | Free Full-Text | Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention | HTML](https://www.mdpi.com/ijerph/ijerph-19-06555/article_deploy/html/images/ijerph-19-06555-g001.png)
IJERPH | Free Full-Text | Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention | HTML
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in
An upper bound visualization of design trade-offs in adsorbent materials for gas separations: alkene/alkane adsorbents
![An upper bound visualization of design trade-offs in adsorbent materials for gas separations: alkene/alkane adsorbents - Chemical Communications (RSC Publishing) DOI:10.1039/D1CC02350K An upper bound visualization of design trade-offs in adsorbent materials for gas separations: alkene/alkane adsorbents - Chemical Communications (RSC Publishing) DOI:10.1039/D1CC02350K](https://pubs.rsc.org/image/article/2021/CC/d1cc02350k/d1cc02350k-f3_hi-res.gif)
An upper bound visualization of design trade-offs in adsorbent materials for gas separations: alkene/alkane adsorbents - Chemical Communications (RSC Publishing) DOI:10.1039/D1CC02350K
![PDF) Playing Mahjong for 12 Weeks Improved Executive Function in Elderly People With Mild Cognitive Impairment: A Study of Implications for TBI-Induced Cognitive Deficits PDF) Playing Mahjong for 12 Weeks Improved Executive Function in Elderly People With Mild Cognitive Impairment: A Study of Implications for TBI-Induced Cognitive Deficits](https://i1.rgstatic.net/publication/340242810_Playing_Mahjong_for_12_Weeks_Improved_Executive_Function_in_Elderly_People_With_Mild_Cognitive_Impairment_A_Study_of_Implications_for_TBI-Induced_Cognitive_Deficits/links/5e806a74a6fdcc139c10477c/largepreview.png)
PDF) Playing Mahjong for 12 Weeks Improved Executive Function in Elderly People With Mild Cognitive Impairment: A Study of Implications for TBI-Induced Cognitive Deficits
![IJERPH | Free Full-Text | Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention | HTML IJERPH | Free Full-Text | Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention | HTML](https://www.mdpi.com/ijerph/ijerph-19-06555/article_deploy/html/images/ijerph-19-06555-g003.png)
IJERPH | Free Full-Text | Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention | HTML
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in
![PDF) Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): Diagnosis, treatment, therapy and future perspectives PDF) Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): Diagnosis, treatment, therapy and future perspectives](https://i1.rgstatic.net/publication/349904527_Nanotechnology_against_the_novel_coronavirus_severe_acute_respiratory_syndrome_coronavirus_2_Diagnosis_treatment_therapy_and_future_perspectives/links/604fcd30a6fdccbfeae1bec8/largepreview.png)
PDF) Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): Diagnosis, treatment, therapy and future perspectives
![Pharmaceutics | Free Full-Text | Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives | HTML Pharmaceutics | Free Full-Text | Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01117/article_deploy/html/images/pharmaceutics-14-01117-g003.png)
Pharmaceutics | Free Full-Text | Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives | HTML
![Molecules | Free Full-Text | Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations | HTML Molecules | Free Full-Text | Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations | HTML](https://www.mdpi.com/molecules/molecules-25-05294/article_deploy/html/images/molecules-25-05294-g001-550.jpg)